Skip to main content
. 2022 May 30;9:783592. doi: 10.3389/fmed.2022.783592

Figure 2.

Figure 2

Correlation analyses between CAPN2 mRNA levels and different clinicopathological characteristics of patients with PC. The association between CAPN2 levels and clinicopathological characteristics of patients with PC, including (A) age (P = 0.97); (B) sex (P = 0.2844); (C) tumor grade (G) stage (P = 0.035); (D) tumor (T) stage (P = 0.0129); (E) node N stage (P = 0.969); (F) metastasis M stage (P = 0.7694); (G) tumor node metastasis (TNM) stage (P = 0.7721); (H) radiotherapy (P = 0.6861); (I) tumor status (P = 0.035).